More research is needed to define the role of doxycycline, minocycline, and azithromycin in this difficult-to-treat condition. Medscape Medical News
Uncategorized
PDEK with glued IOL, pupilloplasty may be effective for endothelial decompensation
The combination of glue-assisted intrascleral IOL fixation with pupilloplasty and pre-Descemet’s endothelial keratoplasty may be effective in some cases of endothelial decompensation, according to a study.Five eyes underwent the single-stage procedure, in which glued IOL fixation was performed to secure the IOL before pupilloplasty was done to stabilize the anterior chamber and prevent air diversion into the vitreous cavity. PDEK was then performed.
Better Imaging, Better Detection and Treatment
Dr Julia Haller and her colleagues at Wills Eye Hospital provide a recap on the American Academy of Ophthalmology meeting, including advances in imaging that are revolutionizing the field. Wills Eye Hospital
Uncategorized
Post-Ebola syndrome poses threat of ocular complications
Ebola hemorrhagic fever is a deadly disease caused by several species of Ebolavirus, a RNA virus of the Filoviridae family. This virus outbreak continues to affect different parts of Africa, and an outbreak reported in the Democratic Republic of the Co…
Uncategorized
VIDEO: Inaugural FLOREtina meeting embraces ‘best of the retinal world’
FLORENCE, Italy — The first edition of the FLOREtina International Congress greeted about 1,500 attendees and about 100 speakers, and included 2 days of live surgery transmitted from the operating room of University Hospital of Florence. Stanislao Rizzo, MD, one of the meeting organizers, speaks about the scientific program.
Ocata Reports the Publication of Data about the Generation of Corneal Endothelial Cells from Human Pluripotent Stem Cells
MARLBOROUGH, Mass.–(BUSINESS WIRE)–Ocata Therapeutics, Inc. (OCAT), a leader in the field of regenerative medicine, reported today that early research was published in the journal PLOS One (online, December 21, 2015) by Ocata and its collaborators at the University of Miami, UCSD, and Stanford University. The publication presents a method for generating scalable amounts of human embryonic stem cell derived corneal endothelial cells (hESC-CEC). “Disease and injury to the cornea are leading cau